Results 201 to 210 of about 32,799 (334)

Comment on "Propensity score-matched analysis comparing drains and no-drains in rectal cancer surgery: the value of using a hemostatic agent instead". [PDF]

Int J Surg
Sun YH, Cai WR, Zou KJ.
europepmc   +1 more source

Histopathological effects of Algan hemostatic agent (AHA) in liver injury model in rats. [PDF]

Hepatol Forum, 2022
Sener D, Kocak M, Saracoglu R, Deveci U, Karadag M.   +4 more
europepmc   +1 more source

Effectiveness of Local Hemostatic Agents in Epistaxis

, 2014
Tahir Hussain
openalex   +1 more source

Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet, Siddhartha Mengi, David Garcia Labbé, Can Manh Nguyen, Jean‐Michel Paradis   +4 more
wiley   +1 more source

Indocyanine green used in association with a surgical hemostatic agent as a fiducial marker to reduce overflow during robot-assisted thoracic surgery. [PDF]

J Bras Pneumol
Mendes GF, Arcuri MF, Falsarella PM, Rassi Neto A, Garcia RG.   +4 more
europepmc   +1 more source

Comparative evaluation of the effect of two natural collagen cross-linkers on microtensile bond strength of self-etch adhesive system to dentin after contamination with blood and hemostatic agent: An in vitro study. [PDF]

J Conserv Dent Endod, 2023
Manihani AKDS, Mulay S, Beri L, Tandale A, Bhawalkar A, Dalsania R.   +5 more
europepmc   +1 more source

Proteolytic enzyme systems [PDF]

, 1993
Fritz, Hans, Jochum, Marianne, Machleidt, W., Redl, H., Schlag, Günther   +4 more
core   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Commentary on "Propensity score-matched analysis comparing drains and no-drains in rectal cancer surgery: the value of using a hemostatic agent instead. A prospective observational study". [PDF]

Int J Surg
Ren W, Hou Q.
europepmc   +1 more source

Theoretical modeling of coagulation management with therapeutic plasma or prothrombin complex concentrate [PDF]

, 2017
Collins, Dusel, Grottke, Hanke, Herbert Schöchl, Ken Sutor, Kieron Dony, Kozek-Langenecker, Marco Ranucci, Martin Schreiber, Mitrophanov, Mitrophanov, Oliver Grottke, Peter W. Collins, Sanfelippo, Sniecinski, Sørensen   +16 more
core   +1 more source